Search Results 2081-2090 of 16177 for Epilepsy (Partial Onset)

  1. Developing Novel Microbiota-Targeted Therapies for Irritable Bowel Syndrome - Mayo Clinic

    Antibiotic use within the past 4 weeks (they can be enrolled after a four-week washout period and subsequent use during the 6-month study duration does not ...

  2. Extending Preservation and Assessment Time of Donor Lungs Using the Toronto EVLP System™ at a Dedicated EVLP Facility - Mayo Clinic

    This is a safety study to compare the safety of receiving a lung treated with the Toronto EVLP System™ by SPONSOR in SPONSOR's dedicated facility against ...

  3. Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF) - Mayo Clinic

    The purpose of this study is to assess the safety of EXE-346 after 4 weeks of treatment in subjects with an Ileal-Pouch Anal Anastomosis (IPAA) and high bowel ...

  4. Safety and Tolerability of GTX-104 Compared With Oral Nimodipine in Patients With aSAH - Mayo Clinic

    Able to start IP within 96 hours from the onset of aSAH. Note 1: The onset of aSAH is defined as the time when the subject experienced the first symptom of ...

  5. Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD) - Mayo Clinic

    During the early phases (phases 1 and 2), researchers assess safety ... (condom) with a spermicide for the duration of treatment and for at least 48 hours

  6. Cardiovascular Research Center - Early Phase Clinical Trials Program

    Beginning setup with internal service areas. Stage 4: Study setup. In this final stage, our program team completes site activation in preparation for ...

  7. A Study to Evaluate the Effectiveness, Safety, and Tolerability of BOS-589 in the Treatment of Patients with Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) - Mayo Clinic

    About this study. The purpose of this study is to evaluate abdominal pain response to BOS-589 in participants with diarrhea-predominant Irritable Bowel ...

  8. Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID) - Mayo Clinic

    During the early phases (phases 1 and 2), researchers assess safety, side ... duration of the trial: HD ≥2 times per week or PD ≥4 times per week ...

  9. In the Loop: Living with ALS - raising awareness and money for research - Mayo Clinic News Network

    Mayo Clinic Q and A: Deep brain stimulation may reduce seizures caused by epilepsy. Related Articles. Cardiovascular. AI-enhanced echocardiography improves ...

  10. Mayo Clinic Q&A podcast: Building resilience in children during COVID-19

    Learn more about tracking COVID-19 and COVID-19 trends. Innovative treatment brings relief to man who experienced hundreds of seizures daily · COVID-19 ...